In the US, Enoxacin (enoxacin systemic) is a member of the drug class quinolones and is used to treat Epididymitis - Non-Specific, Gonococcal Infection - Uncomplicated, Kidney Infections, Prostatitis and Urinary Tract Infection.
US matches:
- Enoxacin
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J01MA04
CAS registry number (Chemical Abstracts Service)
0074011-58-8
Chemical Formula
C15-H17-F-N4-O3
Molecular Weight
320
Therapeutic Category
Antibacterial: Gyrase inhibitor
Chemical Name
1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
Foreign Names
- Enoxacinum (Latin)
- Enoxacin (German)
- Énoxacine (French)
- Enoxacino (Spanish)
Generic Names
- Enoxacin (OS: BAN, JAN, USAN)
- Enoxacina (OS: DCIT)
- Énoxacine (OS: DCF)
- AT 2266 (IS: Dainippon)
- CI 919 (IS: Parke-Davis)
- PD 107779 (IS)
- Enoxacin (PH: JP XIV)
- Enoxacin Hydrate (PH: JP XV)
Brand Names
- Arox
Hikma, United Arab Emirates; Hikma, Bahrain; Hikma, Egypt; Hikma, Iraq; Hikma, Jordan; Hikma, Kuwait; Hikma, Lebanon; Hikma, Libya; Hikma, Qatar; Hikma, Saudi Arabia; Hikma, Sudan; Hikma, Syria; Hikma, Yemen - Enoksetin
Eczacibasi, Turkey - Enoxor
Pierre Fabre, Tunisia - Enoxur
PF, Luxembourg - Flumark
Dainippon Sumitomo, Japan - Enorin
Rowe, Dominican Republic; Rowe, Ecuador - Enoxen
EG, Italy - Enoxor
PF, Luxembourg; Pierre Fabre, Germany; Pierre Fabre Médicament, France
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment